Clinical Psychopharmacology and Neuroscience

Papers
(The TQCC of Clinical Psychopharmacology and Neuroscience is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Kynurenine Pathway of Tryptophan Metabolism in Neuropsychiatric Disorders: Pathophysiologic and Therapeutic Considerations77
Effects of Non-invasive Neurostimulation on Autism Spectrum Disorder: A Systematic Review50
The Psychological Impact of COVID-19 Disease is more Severe on Intensive Care Unit Healthcare Providers: A Cross-sectional Study44
Nutritional Neuroscience as Mainstream of Psychiatry: The Evidence- Based Treatment Guidelines for Using Omega-3 Fatty Acids as a New Treatment for Psychiatric Disorders in Children and Adolescents38
Cariprazine Add-on in Inadequate Clozapine Response: A Report on Two Cases30
Rapid Onset of Intranasal Esketamine in Patients with Treatment Resistant Depression and Major Depression with Suicide Ideation: A Meta-Analysis28
Telephone based Interventions for Psychological Problems in Hospital Isolated Patients with COVID-1927
Second-to-Fourth Digit Ratio (2D:4D) in Psychiatric Disorders: A Systematic Review of Case-control Studies25
Personalization of Repetitive Transcranial Magnetic Stimulation for the Treatment of Major Depressive Disorder According to the Existing Psychiatric Comorbidity24
Biomarkers of Major Depressive Disorder: Knowing is Half the Battle24
Apathy: Neurobiology, Assessment and Treatment24
Standardization of the Korean Version of the Patient Health Questionnaire-4 (PHQ-4)23
Role of Transcranial Direct Current Stimulation in the Management of Alzheimer’s Disease: A Meta-analysis of Effects, Adherence and Adverse Effects23
Computational Neuroscience Approach to Psychiatry: A Review on Theory-driven Approaches21
Elevated Monocyte to High-density Lipoprotein Ratios as an Inflammation Markers for Schizophrenia Patients20
Anhedonia and Depressive Disorders20
White Matter Alterations Associated with Pro-inflammatory Cytokines in Patients with Major Depressive Disorder20
Prevalence and Comorbidities of Attention Deficit Hyperactivity Disorder Among Adults and Children/Adolescents in Korea20
Neurological Adverse Reactions to SARS-CoV-2 Vaccines18
Psychobiotic Therapy: Method to Reinforce the Immune System17
Decline in Hospital Visits by Patients with Schizophrenia Early in the COVID-19 Outbreak in Korea16
Factors Associated with Doses of Mood Stabilizers in Real-world Outpatients with Bipolar Disorder16
Recent Advances in the Pharmacology of Tardive Dyskinesia15
Machine Learning and Deep Learning for the Pharmacogenomics of Antidepressant Treatments14
How to Utilize Clinical and Genetic Information for Personalized Treatment of Major Depressive Disorder: Step by Step Strategic Approach14
Drug-induced Hyperthermic Syndromes in Psychiatry14
Evaluation Expression of the Caspase-3 and Caspase-9 Apoptotic Genes in Schizophrenia Patients14
Efficacy of Ulinastatin and Sulforaphane Alone or in Combination in Rat Model of Streptozotocin Diabetes Induced Vascular Dementia13
Trazodone Add-on in COVID-19-related Selective Serotonin Reuptake Inhibitor-resistant Post-traumatic Stress Disorder in Healthcare Workers: Two Case Reports13
Improved Executive Functions and Reduced Craving in Youths with Methamphetamine Addiction: Evidence from Combined Transcranial Direct Current Stimulation with Mindfulness Treatment13
Novel Biomarkers of Alzheimer's Disease: Based Upon N-methyl-D-aspartate Receptor Hypoactivation and Oxidative Stress13
Effect of Self-administered Transcranial Direct Stimulation in Patients with Major Depressive Disorder: A Randomized, Single-blinded Clinical Trial12
Autism-like Behaviors in Male Juvenile Offspring after Maternal Glyphosate Exposure12
Potential Candidates for Biomarkers in Bipolar Disorder: A Proteomic Approach through Systems Biology11
Neuromolecular Etiology of Bipolar Disorder: Possible Therapeutic Targets of Mood Stabilizers11
The Clinical Observation of Inflammation Theory for Depression: The Initiative of the Formosa Long COVID Multicenter Study (FOCuS)11
Long-term Safety and Efficacy of Esketamine Nasal Spray Plus an Oral Antidepressant in Patients with Treatment-resistant Depression– an Asian Sub-group Analysis from the SUSTAIN-2 Study10
Vortioxetine Treatment for Depression in Alzheimer’s Disease: A Randomized, Double-blind, Placebo-controlled Study10
Proposed Pathway Linking Respiratory Infections with Depression10
Anxiety, Depression and Burnout Levels of Turkish Healthcare Workers at the End of the First Period of COVID-19 Pandemic in Turkey10
‘Z-trip’? A Comprehensive Overview and a Case-series of Zolpidem Misuse10
Add-on Cariprazine in Patients with Long-term Clozapine Treatment and Treatment Resistant Schizophrenia: Two Cases of Psychotic Deterioration and Pisa Syndrome10
Lithium and Valproate in Bipolar Disorder: From International Evidence-based Guidelines to Clinical Predictors10
Effectiveness of N-acetylcysteine in Treating Clinical Symptoms of Substance Abuse and Dependence: A Meta-analysis of Randomized Controlled Trials10
Consideration of Long-Acting Injectable Antipsychotics for Polypharmacy Regimen in the Treatment of Schizophrenia: Put It on the Table or Not?10
Challenges in Prescribing Clozapine in the Era of COVID-19: A Review Focused on Immunological Implications9
Prescription Patterns for Bipolar Disorder in Asian Countries: Findings from Research on Asian Prescription Pattern-Bipolar Disorder9
miR-132 and miR-942 Expression Levels in Children with Attention Deficit and Hyperactivity Disorder: A Controlled Study9
Quantitative Resting State Electroencephalography in Patients with Schizophrenia Spectrum Disorders Treated with Strict Monotherapy Using Atypical Antipsychotics9
Prediction Models for Suicide Attempts among Adolescents Using Machine Learning Techniques9
Efficacy and Safety of Escitalopram, Desvenlafaxine, and Vortioxetine in the Acute Treatment of Anxious Depression: A Randomized Rater-blinded 6-week Clinical Trial9
A Study of Psychological Factors Associated with Functional Gastrointestinal Disorders and Use of Health Care8
Rapid Symptom Improvement in Major Depressive Disorder Using Accelerated Repetitive Transcranial Magnetic Stimulation8
Korean Medication Algorithm for Depressive Disorder 2021, Fourth Revision: An Executive Summary8
Significant Shortening of Leukocyte Telomere Length in Korean Patients with Bipolar Disorder 18
Effectiveness and Tolerability of Korean Red Ginseng Augmentation in Major Depressive Disorder Patients with Difficult-to-treat in Routine Practice8
Relationship Between the Loudness Dependence of the Auditory Evoked Potential and the Severity of Suicidal Ideation in Patients with Major Depressive Disorder8
A Different View on the Etiopathogenesis of Attention-deficit Hyperactivity Disorder from an Inflammation Perspective8
Korean Medication Algorithm Project for Bipolar Disorder 2022: Comparisons with Other Treatment Guidelines8
Adherence to Antipsychotic Drugs by Medication Possession Ratio for Schizophrenia and Similar Psychotic Disorders in the Republic of Korea: A Retrospective Cohort Study8
First Manic Attack During COVID-19 Treatment: A Case Report8
Brain-derived Neurotrophic Factor and High Sensitive C-reactive Protein in Bipolar Depression and Unipolar Depression: The Practical Usage as a Discriminatory Tool8
The Role of Glutamate Underlying Treatment-resistant Depression8
Korean Medication Algorithm Project for Bipolar Disorder 2022, Fifth Revision: An Executive Summary8
Does the Loudness Dependence of Auditory Evoked Potential Predict Response to Selective Serotonin Reuptake Inhibitors?: A Meta-analysis8
Targeting Three Brain Regions (Bilateral SMA, Left and Right DLPFC) Sequentially in One Session Using Combined Repetitive Transcranial Magnetic Stimulation and Intermittent Theta-burst Stimulation in 7
Classifying Children with ADHD Based on Prefrontal Functional Near-infrared Spectroscopy Using Machine Learning7
DNA Methylation Pattern of Gene Promoters of MB-COMT, DRD2, and NR3C1 in Turkish Patients Diagnosed with Schizophrenia7
Prediction of Locomotor Activity by Infrared Motion Detector on Sleep-wake State in Mice7
Sublingual Dexmedetomidine for the Treatment of Agitation in Patients with Schizophrenia and Bipolar Disorder7
Trough Melatonin Levels Differ between Early and Late Phases of Alzheimer Disease7
Repetitive Transcranial Magnetic Stimulation for Treatment of Trichotillomania: Case Series7
Decreased Cortical Thickness and Local Gyrification in Individuals with Subjective Cognitive Impairment7
Methyl Jasmonate: Behavioral and Molecular Implications in Neurological Disorders7
Evaluation of Changes in Peripheric Biomarkers Related to Blood Brain Barrier Damage in Patients with Schizophrenia and Their Correlation with Symptoms7
COVID-19 Impact on the Italian Community-based System of Mental Health Care: Reflections and Lessons Learned for the Future7
Transcranial Alternating Current Stimulation (tACS) and Its Role in Schizophrenia: A Scoping Review7
Guillain-Barre Syndrome Following SARS-CoV-2 Vaccination: A Case Report7
A Primer on Interoception and its Importance in Psychiatry7
Network Structures of Social Functioning Domains in Schizophrenia and Bipolar Disorder: A Preliminary Study7
An Overview of Deep Learning Algorithms and Their Applications in Neuropsychiatry7
Effects of Vitamin D Supplementation on Children with Autism Spectrum Disorder: A Systematic Review and Meta-analysis7
Selective Serotonin Reuptake-Inhibitors for Symptom-Based Treatment of Borderline Personality Disorders in Older Adults: An International Delphi Study7
Exploring Hidden Issues in the Use of Antipsychotic Polypharmacy in the Treatment of Schizophrenia6
Vortioxetine Induced Hypomania: A Case Presentation and Review of the Literature6
Increased Serum Brain-derived Neurotrophic Factor, Nerve Growth Factor, Glial-derived Neurotrophic Factor and Galanin Levels in Children with Attention Deficit Hyperactivity Disorder, and the Effect o6
Oxidative Stress and Inflammatory Biomarkers in People with Methamphetamine Use Disorder6
Oxytocin and Vasopressin Levels and Related Factors in Adolescents with Social Phobia and Other Anxiety Disorders6
Neutrophil-lymphocyte and Platelet-lymphocyte Ratios among Adolescents with Substance Use Disorder: A Preliminary Study6
Associations among High Risk for Sleep-disordered Breathing, Related Risk Factors, and Attention Deficit/Hyperactivity Symptoms in Elementary School Children6
Multiple Complement Pathway-related Proteins Might Regulate Immunopathogenesis of Major Depressive Disorder6
Predictors of Remission in Acute and Continuation Treatment of Depressive Disorders6
Body Mass Index and Somatic Symptom Severity in Patients with Somatic Symptom Disorder: The Mediating Role of Working Memory6
Additional Reduction of Residual Symptoms with Aripiprazole Augmentation in the Patients with Partially Remitted Major Depressive Disorder6
Clinical Usefulness of Amisulpride Add-on Therapy in Schizophrenia Patients without Treatment Response to Second-generation Antipsychotics6
Lurasidone in Therapy of Treatment-resistant Ultra-rapid Cycling Bipolar Disorder: Case Report6
Cariprazine — an Alternative Treatment for Clozapine-resistant Schizophrenia?6
0.028692007064819